Merkel cell carcinoma associated with tofacitinib therapy

Luke S Wallis; Uros Rakita; Solomiya Grushchak; Sepideh N Asadbeigi; Pedram Yazdan; Wenhua Liu; Aleksandar Krunic

doi:10.1016/j.jdcr.2021.06.011

Merkel cell carcinoma associated with tofacitinib therapy

JAAD Case Rep. 2021 Jun 29:14:94-96. doi: 10.1016/j.jdcr.2021.06.011. eCollection 2021 Aug.

Authors

Luke S Wallis¹, Uros Rakita², Solomiya Grushchak³, Sepideh N Asadbeigi⁴, Pedram Yazdan⁴, Wenhua Liu⁵, Aleksandar Krunic⁴

Affiliations

¹ Department of Dermatology, Rush University Medical Center, Chicago, Illinois.
² Chicago Medical School at Rosalind Franklin University, Chicago, Illinois.
³ Department of Dermatology, Cook County Health and Hospitals System, Chicago, Illinois.
⁴ Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
⁵ Consolidated Pathology Consultants, Libertyville, Illinois.

No abstract available

Keywords: IFN, interferon; IL, interleukin; JAK, Janus-associated kinases; Janus kinase inhibitor; MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel cell carcinoma; STAT, signal transducer and activator of transcription; tofacitinib.

Publication types

Case Reports